Pieris Pharmaceuticals Corporate Presentation June 2023

Pieris Pharmaceuticals presents its pipeline of novel drug candidates including co-stim bispecifics and inhaled therapeutics leveraging its Anticalin platform technology. The presentation outlines the company's product development strategy, clinical programs, and potential market opportunities in respiratory and oncology indications.